Dr. Srinivas Chilukuri is a distinguished Radiation Oncologist based in Chennai, India, with over 22 years of experience in the field. He is affiliated with the Apollo Proton Cancer Centre, where he serves as a Senior Consultant specializing in Pediatric, Urology, and Thoracic Oncology.
Educational Qualifications:
- MBBS
- MD in Radiation Oncology from Tata Memorial Centre, Mumbai, in 2004, completing his training with top university honors.
Professional Experience:
- Senior Consultant - Radiation Oncology: Currently serving at Apollo Proton Cancer Centre, Chennai.
- Consultant at Yashoda Cancer Institute: From June 2008 to March 2018, contributed to the establishment of advanced radiotherapy programs.
- Lead Faculty at Varian Advanced Radiotherapy School: From 2013 to 2018, trained over 220 radiation oncologists and physicists across the Indian subcontinent.
- Consultant-Medical Affairs for Varian Medical Systems: Provided medical and scientific guidance.
- Visiting Professor at Vanderbilt University Medical Centre: In 2013, engaged in academic and clinical collaborations.
Notable Achievements:
- Initiation of Particle Beam Therapy Program: Credited with initiating South Asia and India’s first clinical program for particle beam therapy, focusing on pediatric cancers, prostate cancers, thoracic cancers, and sarcomas.
- Clinical Director for Advanced Radiotherapy School: Trained numerous oncologists and medical physicists in high-precision radiation therapy.
- Co-founder and Chairman of Optimus Oncology: An organization dedicated to providing modern and affordable cancer care to rural areas in India.
Professional Memberships:
- American Society of Clinical Oncology (ASCO)
- American Society of Radiation Oncology (ASTRO)
- European Society of Medical Oncology (ESMO)
- Pediatric Radiation Oncology Society
- Society of Neuro-Oncology
- Association of Radiation Oncologists of India (AROI)
- Indian Society of Neuro-Oncology (ISNO)
Fellowships:
- Radiosurgery Fellowship: Completed at VU University Medical Centre, Amsterdam.
- Fellowships from American Society of Oncology and European Society of Medical Oncology